Systemic Therapeutics Announces the Appointment of Its Executive Team
Hamilton, Ontario--(Newsfile Corp. - January 31, 2022) - Systemic Therapeutics Corp. (the "Company" or "SystemicTx") is a pre-clinical stage, biotechnology...
Day: January 31, 2022
NHI Provides $28.5 Million Development Loan and Expands Encore Senior Living Relationship
MURFREESBORO, TN / ACCESSWIRE / January 31, 2022 / National Health Investors, Inc. (NYSE:NHI) today announced that it will fund...
Eversio Wellness Announces Inclusion on Health Canada’s List of Licensed Psilocybin Producers
SURREY, BC / ACCESSWIRE / January 31, 2022 / Eversio Wellness Ltd. ("Eversio" or the "Company"), a Canadian mushroom wellness...
Neutra’s Aggressive 2022 Strategy Roars Out of the Gates in Quick-Paced January
KATY, TX / ACCESSWIRE / January 31, 2022 / Neutra Corp. (OTC PINK:NTRR) reports that it has kicked off 2022...
Health Systems Gain Competitive Advantage with Tech Enhancements to IT Financial Processes
By Shannon Burke, Senior Vice President and General Manager of Health Systems, Synchrony Health & Wellness Health systems are facing...
RapidAI Announces Karim Karti as New CEO
Former GE Healthcare Imaging and iRhythm leader joins pioneers in clinical decision making and patient care coordination to support continued...
Netsmart myUnity® Achieves Industry First 100% ONC Health IT Certification
The industry’s first base criteria ONC-certified EHR enables palliative care providers to participate in quality incentive programs and alternative payment...
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second doseSPIKEVAX has received...
Aytu BioPharma Completes $15 Million Debt Refinancing
ENGLEWOOD, CO / ACCESSWIRE / January 31, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
Eve & Co Announces Shares for Debt Transaction
STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
-- Phase 3 Sabizabulin COVID-19 Clinical Study for Treatment of Hospitalized Moderate to Severe COVID-19 Patients at High Risk for...
Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Ozop Energy Solutions Receives Department of Insurance Approval
EV Insurance Company, Inc. DBA OZOP Plus Preparing for Launch Florida, NY, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ozop Energy...
Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate
Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of...
Franciscan Health Achieves Center of Excellence Status for Cardio-Oncology Care
Franciscan Health Franciscan Health Indianapolis INDIANAPOLIS, Indiana, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Franciscan Health joins an elite group of...
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data Immix Biopharma, Inc. (NASDAQ:IMMX) Manufactured IMX-110 to be utilized...
Brain Scientific Issues Shareholder Letter and Corporate Update
New CEO foresees revenue growth from commercial medical product launches in $4 billion addressable marketNEW YORK, Jan. 31, 2022 (GLOBE...
Immutep to Present at February Investor Conferences
SYDNEY, AUSTRALIA, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
LEXINGTON, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...